Achieve Life Sciences is a single-asset microcap centered on cytisinicline, with an accepted NDA and a June 20, 2026, PDUFA.

Analysts expect a record-breaking Q4 2025, with revenue projected to hit approximately $211.3B and EPS at $1.97, driving ...

Flexsteel managed to capture significant market share through improved product lines and expanded distribution. See why I ...

Banco Santander (Brasil)'s net interest income from lending rose 6.6% YoY, but overall NII fell 4% due to market securities ...

For full-year 2025, Regal Rexnord ( RRX) reported net income of $280.8 million and adjusted earnings of $9.65 a share. The ...

Bond market signals point to higher U.S. rates, anchored inflation, and slower growth. Read more macro analysis here.

The ADP employment report revealed that 22,000 nonfarm private jobs were added in January, down from the 37,000 added in ...

Canada’s private-sector activity remained soft in January, with the S&P Global Canada Composite PMI coming in at 46.4, ...

Alphabet Inc. is rated a Buy due to strong revenue growth, rising efficiency and heavy AI investment. Learn more about GOOGL ...

Search +17% YoY, Cloud +48%, $240B backlog, CapEx ramp. Click for this close look at GOOGL stock earnings performance.

Most of Nu Holdings' money comes from digital accounts, cash deposits, or balances that pay little or nothing. In practice, ...

Buy despite FY2026 headwinds, pricing pressure, and margin risks. Click for this NVO earnings update and why I am bullish.